Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced that it hosted a virtual R&D day event, during which it discussed its ion channel drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results